AVITA Medical, Inc.

NasdaqCM:RCEL Rapporto sulle azioni

Cap. di mercato: US$337.3m

AVITA Medical Gestione

Gestione criteri di controllo 2/4

AVITA Medical Il CEO è Jim Corbett, nominato in Sep2022, e ha un mandato di 2.17 anni. la retribuzione annua totale è $ 2.07M, composta da 30.2% di stipendio e 69.8% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.033% delle azioni della società, per un valore di $ 111.65K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 6.1 anni.

Informazioni chiave

Jim Corbett

Amministratore delegato

US$2.1m

Compenso totale

Percentuale dello stipendio del CEO30.2%
Mandato del CEO2.2yrs
Proprietà del CEO0.03%
Durata media del management1.8yrs
Durata media del Consiglio di amministrazione6.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Oct 04
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Aug 11
AVITA Medical, Inc. (NASDAQ:RCEL) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 18
AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Jun 18
Is AVITA Medical (NASDAQ:RCEL) A Risky Investment?

Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

Apr 12
Little Excitement Around AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues As Shares Take 39% Pounding

AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

Feb 02
AVITA Medical, Inc.'s (NASDAQ:RCEL) Price Is Right But Growth Is Lacking After Shares Rocket 39%

The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Oct 20
The Market Doesn't Like What It Sees From AVITA Medical, Inc.'s (NASDAQ:RCEL) Revenues Yet As Shares Tumble 32%

Avita Medical appoints James Corbett as CEO

Sep 29

AVITA Medical says trial evaluating its RECELL system to treat vitiligo met main goal

Sep 12

Avita's burn therapy Recell gets insurance coverage in Japan following approval

Sep 01

AVITA Medical GAAP EPS of -$0.25 beats by $0.15, revenue of $8.34M beats by $1.18M

Aug 11

AVITA Medical Is Interesting, But Not Just Yet

Dec 21

AVITA Medical reports preliminary Q2 revenue in-line with consensus

Jan 12

AVITA: COVID-19's Impact

Nov 17

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jim Corbett rispetto agli utili di AVITA Medical?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$57m

Jun 30 2024n/an/a

-US$50m

Mar 31 2024n/an/a

-US$45m

Dec 31 2023US$2mUS$625k

-US$35m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$31m

Mar 31 2023n/an/a

-US$26m

Dec 31 2022US$2mUS$157k

-US$27m

Sep 30 2022n/an/a

-US$30m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$256kn/a

-US$25m

Compensazione vs Mercato: La retribuzione totale di Jim ($USD 2.07M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 2.12M ).

Compensazione vs guadagni: La retribuzione di Jim è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Jim Corbett (66 yo)

2.2yrs

Mandato

US$2,068,675

Compensazione

Mr. James M. Corbett, also known as Jim, served as Chief Executive Officer of CathWorks Ltd. since October 27, 2017 until 2021. He serves as Director of CathWorks Ltd.until 2021. He served as an Independe...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
James Corbett
CEO, President & Executive Director2.2yrsUS$2.07m0.033%
$ 111.7k
David O'Toole
Chief Financial Officer1.4yrsUS$2.18mNessun dato
David Fencil
Senior Vice President of Global Operations1.8yrsNessun datoNessun dato
Katie Bush
Senior Vice President of Scientific & Medical Affairsless than a yearNessun datoNessun dato
Jessica Ekeberg
Investor Relations Executiveno dataNessun datoNessun dato
Nicole Kelsey
Chief Legal & Compliance Officer and Corporate Secretaryless than a yearNessun datoNessun dato
Debbie Garner
Senior Vice President of Global Marketing & Strategy6.3yrsNessun datoNessun dato
Rob Hall
Senior Vice President of Human Resources1.8yrsNessun datoNessun dato
Niraj Doshi
Senior Vice President of Product Development & Program Management1.8yrsNessun datoNessun dato
Ron Lagerquist
Senior Vice President of Quality Assurance & Regulatory Affairs1.8yrsNessun datoNessun dato
Robin VanDenburgh
Senior Vice President of U.S. Commercial Salesless than a yearNessun datoNessun dato

1.8yrs

Durata media

Gestione esperta: Il team dirigenziale di RCEL non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
James Corbett
CEO, President & Executive Director3.3yrsUS$2.07m0.033%
$ 111.7k
Jan Reed
Independent Non-Executive Director3.3yrsUS$211.12k0.11%
$ 371.4k
Jeremy Curnock-Cook
Independent Non-Executive Director12.1yrsUS$199.87k0.079%
$ 264.9k
Fiona Wood
Founder and Member of Clinical Advisory Board8.8yrsUS$29.80kNessun dato
Louis Panaccio
Independent Non-Executive Chairman10.3yrsUS$234.69k0.16%
$ 554.9k
Robert McNamara
Independent Non-Executive Director1.6yrsUS$369.11k0.075%
$ 252.3k
Cary Vance
Independent Non-Executive Director1.6yrsUS$364.94k0.037%
$ 123.8k
Suzanne Crowe
Independent Non-Executive Director8.8yrsUS$195.28k0.10%
$ 349.9k

6.1yrs

Durata media

67yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di RCEL sono considerati esperti (durata media dell'incarico 6.1 anni).